NCT01288898View on ClinicalTrials.gov

Multiple Dose Escalating Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1941

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Healthy
Interventions
DRUG

ASP1941

Oral

DRUG

Placebo

Oral

Trial Locations (1)

9470 AE

Groningen

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY